1,217 jobs are currently under threat at the pharmaceutical company GSK in Belgium.

Omissions

• The 1,217 figure is a ceiling ('up to 1,217'), not a finalised number of redundancies; the cuts are subject to a works council information-consultation procedure that could still change the outcome.
• The restructuring is a three-year global cost-saving plan; the Belgian cuts break down into 735 managers and 482 other employees, and GSK employs more than 8,000 people in Belgium (Rixensart, Wavre and Gembloux), so the claim omits that context.
• No GSK corporate press release was located; the verification rests on independent news reporting (Reuters, VRT, Le Monde, RTL, Le Soir) all based on the 14 October 2026 works council announcement, i.e. six days before the plenary speech.

Sources

• SecondaryReuters (via Euronext Live financial news)GSK said on Wednesday it could cut as many as 1217 jobs in Belgium... The proposed cuts would affect some of its more than 8,000 employees at sites in Rixensart, Wavre and Gembloux, but would not include factory...
• SecondaryVRT NWS1217 jobs are at risk at pharmaceutical giant GSK in Wallonia the company has announced at a special works council.
• SecondaryLe MondeRestructuration chez GSK : 1 217 emplois menacés en Wallonie... Manifestation devant le site du fabricant de vaccins GSK à Wavre, le 15 octobre 2026, qui a annoncé la suppression de 1 200 emplois.
• SecondaryLe SoirLa restructuration annoncée mercredi, qui pourrait s'étaler sur deux ans, prévoit la suppression d'un maximum de 1.217 postes, dont 735 cadres...
• SecondaryFierce BiotechUp to 1,217 GSK employees in Belgium are at risk of losing their jobs as the Big Pharma rolls out its global cost-saving strategy.